EP 1179065 A2 20020213 - FULL-LENGTH MOLECULES EXPRESSED IN HUMAN TISSUES
Title (en)
FULL-LENGTH MOLECULES EXPRESSED IN HUMAN TISSUES
Title (de)
VOLLSTÄNDIGE MOLEKÜLE DIE IN MENSCHLICHE GEWEBEN EXPRIMIERT SIND
Title (fr)
MOLECULES COMPLETES EXPRIMEES DANS DES TISSUS HUMAINS
Publication
Application
Priority
- US 0013299 W 20000512
- US 31189499 A 19990514
- US 31194099 A 19990514
- US 31193799 A 19990514
Abstract (en)
[origin: WO0070047A2] The invention provides full-length molecules expressed in human tissues (FLEXHT) and polynucleotides which identify and encode FLEXHT. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for analyzing human gene expression, genetic linkage, and genetic variability, and diagnosing, treating, or preventing disorders associated with expression of FLEXHT.
IPC 1-7
C12N 15/12; C12Q 1/68; C07K 14/47; C07K 16/18; A01K 67/027; A61K 38/17; G01N 33/68
IPC 8 full level
G01N 33/50 (2006.01); A61K 31/7088 (2006.01); A61K 35/76 (2006.01); A61K 38/00 (2006.01); A61K 39/395 (2006.01); A61K 45/00 (2006.01); A61K 48/00 (2006.01); A61P 1/16 (2006.01); A61P 3/10 (2006.01); A61P 7/06 (2006.01); A61P 9/10 (2006.01); A61P 11/00 (2006.01); A61P 13/00 (2006.01); A61P 17/06 (2006.01); A61P 19/02 (2006.01); A61P 19/06 (2006.01); A61P 19/10 (2006.01); A61P 21/04 (2006.01); A61P 25/00 (2006.01); A61P 25/08 (2006.01); A61P 25/14 (2006.01); A61P 27/06 (2006.01); A61P 27/16 (2006.01); A61P 29/00 (2006.01); A61P 31/18 (2006.01); A61P 35/00 (2006.01); A61P 35/02 (2006.01); A61P 37/00 (2006.01); C07K 14/47 (2006.01); C07K 16/18 (2006.01); C12N 1/15 (2006.01); C12N 1/19 (2006.01); C12N 1/21 (2006.01); C12N 5/10 (2006.01); C12N 15/09 (2006.01); C12N 15/12 (2006.01); C12P 21/02 (2006.01); C12Q 1/68 (2006.01); G01N 33/15 (2006.01); G01N 33/53 (2006.01); G01N 37/00 (2006.01)
CPC (source: EP)
A61P 1/16 (2017.12); A61P 3/10 (2017.12); A61P 7/06 (2017.12); A61P 9/10 (2017.12); A61P 11/00 (2017.12); A61P 13/00 (2017.12); A61P 17/06 (2017.12); A61P 19/02 (2017.12); A61P 19/06 (2017.12); A61P 19/10 (2017.12); A61P 21/04 (2017.12); A61P 25/00 (2017.12); A61P 25/08 (2017.12); A61P 25/14 (2017.12); A61P 27/06 (2017.12); A61P 27/16 (2017.12); A61P 29/00 (2017.12); A61P 31/18 (2017.12); A61P 35/00 (2017.12); A61P 35/02 (2017.12); A61P 37/00 (2017.12); C07K 14/47 (2013.01); A01K 2217/05 (2013.01); A61K 38/00 (2013.01)
Citation (search report)
See references of WO 0070047A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0070047 A2 20001123; WO 0070047 A3 20010628; AU 5134600 A 20001205; CA 2373191 A1 20001123; EP 1179065 A2 20020213; JP 2002543839 A 20021224
DOCDB simple family (application)
US 0013299 W 20000512; AU 5134600 A 20000512; CA 2373191 A 20000512; EP 00935966 A 20000512; JP 2000618453 A 20000512